Viewing Study NCT01754857


Ignite Creation Date: 2025-12-24 @ 6:48 PM
Ignite Modification Date: 2026-02-17 @ 4:41 PM
Study NCT ID: NCT01754857
Status: COMPLETED
Last Update Posted: 2023-06-27
First Post: 2012-11-09
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Bendamustine and Rituximab Induction Therapy and Maintenance Rituximab and Lenalidomide in Previously Untreated CLL/SLL
Sponsor: University of Wisconsin, Madison
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lymphoid Leukemia View
None Small Lymphocytic Lymphoma View
None Lymphoma, Non-Hodgkin View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Lymphoid Leukemia View
None Bendamustine View
None Rituximab View
None Small Lymphocytic Lymphoma View